Misguided angiogenesis, plexiform pulmonary hypertension
Misguided angiogenesis, plexiform pulmonary hypertension
批准号:
7120000
负责人:
NORBERT F VOELKEL
金额:
$23.26万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
angiogenesisathymic mousecell growth regulationcell population studycell proliferationdisease /disorder etiologygene expressiongene mutationgrowth factor receptorshuman subjecthuman tissuemicroarray technologymolecular pathologypatient oriented researchpulmonary hypertensiontissue /cell culturetransforming growth factorsvascular endothelial growth factorsvascular endothelium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Primary pulmonary hypertension (PPH) is a devastating disease that occurs in a familial
and a sporadic form, sometimes associated with AIDS, anorexigen drug intake and
with chronic liver disease. We have found that PPH is categorically different from
plexogenic secondary pulmonary hypertension (2nd PH) in that the proliferative
endothelial cells in PPH are monoclonal, whereas they are strictly polyclonal
in secondary PH. We postulate that the exuberant endothelial cell
proliferation in severe pulmonary hypertension occurs - at least in part -because
of mutations of endothelial cell genes involved in apoptosis and
growth control. We further postulate that the pathogenesis of PPH can be
understood by investigating the concept of misguided
vasculogenesis/angiogenesis. Our approach will be to compare pulmonary
vascular lesions from patients with PPH that are monoclonal with those from
patients that are polyclonal and analyze (using the microarray gene chip
technology), the expression pattern in these and in normal lung tissue. The
DNA obtained from pulmonary hypertensive vascular lesions will be extracted
and subjected to mutational analysis. The focus of the mutational analysis
will be on genes associated with endothelial cell growth and apoptosis
control. In order to assess the functional importance of VEGF in the
development of endothelial cell proliferation and formation of obliterative
lesions in PPH lungs we plan to examine to what degree ECV cells that
proliferate under high shear stress conditions express an angiogenesis gene
pattern. We postulate that endothelial cells which carry a mutation of the
TGF-B II gene have a growth advantage and that they will seed at sites of
pulmonary arterial bifurcations after they have been injected into the tail
vein of nude mice. We will grow circulating endothelial cells from patients
with PPH and 2nd PH in culture and examine whether they seed the lung
circulation of nude mice and form obliterating lesions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bone marrow-derived precursor cells and angioproliferative PH
-
批准号:8176298
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2011
-
负责人:NORBERT F VOELKEL
-
依托单位:
Bone marrow-derived precursor cells and angioproliferative PH
-
批准号:8302191
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2011
-
负责人:NORBERT F VOELKEL
-
依托单位:
Misguided angiogenesis, plexiform pulmonary hypertension
-
批准号:6642927
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6780965
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6666770
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6570697
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6923700
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6642859
-
项目类别:
-
资助金额:$110.26万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6367527
-
项目类别:
-
资助金额:$123.59万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6756738
-
项目类别:
-
资助金额:$13.01万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6932438
-
项目类别:
-
资助金额:$116.32万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6779908
-
项目类别:
-
资助金额:$113.7万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6527690
-
项目类别:
-
资助金额:$106.7万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
ENDOTHELIAL CELL PROLIFERATION IN PPH
-
批准号:6184752
-
项目类别:
-
资助金额:$23.13万
-
财政年份:1998
-
负责人:NORBERT F VOELKEL
-
依托单位:
ENDOTHELIAL CELL PROLIFERATION IN PPH
-
批准号:2688228
-
项目类别:
-
资助金额:$32.45万
-
财政年份:1998
-
负责人:NORBERT F VOELKEL
-
依托单位:
ENDOTHELIAL CELL PROLIFERATION IN PPH
-
批准号:6044043
-
项目类别:
-
资助金额:$27.27万
-
财政年份:1998
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN IN SYNTHESIS PULMONARY HYPERTENSION
-
批准号:2220915
-
项目类别:
-
资助金额:$21.84万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN IN SYNTHESIS PULMONARY HYPERTENSION
-
批准号:3361720
-
项目类别:
-
资助金额:$20.5万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN SYNTHESIS IN PULMONARY HYPERTENSION
-
批准号:6151269
-
项目类别:
-
资助金额:$26.52万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN SYNTHESIS IN PULMONARY HYPERTENSION
-
批准号:2872896
-
项目类别:
-
资助金额:$22.31万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
海外基金